We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$9.04B
AUM Growth
+$2.19B
Cap. Flow
+$1.88B
Cap. Flow %
20.78%
Top 10 Hldgs %
34.88%
Holding
3,092
New
1,032
Increased
581
Reduced
587
Closed
820

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$435M
2
AMZN icon
Amazon
AMZN
+$334M
3
MRNA icon
Moderna
MRNA
+$53.9M
4
LIN icon
Linde
LIN
+$44.2M
5
DTE icon
DTE Energy
DTE
+$43.5M

Sector Composition

Rank Sector Weight
1 Technology 15.37%
2 Consumer Discretionary 10.36%
3 Financials 7.14%
4 Industrials 6.8%
5 Healthcare 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PINE
1976
Alpine Income Property Trust
PINE
$347M
$203K ﹤0.01%
+10,678
New +$195K
PSO icon
1977
Pearson
PSO
$9.98B
$203K ﹤0.01%
17,500
-13,900
-44% -$162K
QCLN icon
1978
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$584M
$203K ﹤0.01%
+2,926
New +$186K
LL
1979
DELISTED
LL Flooring Holdings, Inc.
LL
$203K ﹤0.01%
9,614
-9,750
-50% -$230K
ALCO icon
1980
Alico
ALCO
$304M
$201K ﹤0.01%
+5,656
New +$179K
WLDN icon
1981
Willdan Group
WLDN
$1.3B
$201K ﹤0.01%
5,336
-9,831
-65% -$380K
ZD icon
1982
Ziff Davis
ZD
$1.9B
$201K ﹤0.01%
+1,684
New +$185K
SP
1983
DELISTED
SP Plus Corporation
SP
$201K ﹤0.01%
+6,562
New +$215K
KAHC.U
1984
DELISTED
KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant
KAHC.U
$201K ﹤0.01%
20,000
LFMD icon
1985
LifeMD
LFMD
$157M
$200K ﹤0.01%
16,952
+6,670
+65% +$76.7K
YQ
1986
17 Education & Technology Group
YQ
$21.6M
$200K ﹤0.01%
2,743
+1,075
+64% +$115K
BDSX icon
1987
Biodesix
BDSX
$296M
$199K ﹤0.01%
+755
New +$237K
PXLW icon
1988
Pixelworks
PXLW
$42.8M
$199K ﹤0.01%
+4,852
New +$190K
AOMR
1989
Angel Oak Mortgage REIT
AOMR
$196M
$198K ﹤0.01%
+11,097
New +$200K
ECVT icon
1990
Ecovyst
ECVT
$1.11B
$198K ﹤0.01%
12,867
-1,162
-8% -$18.4K
DSKE
1991
DELISTED
Daseke, Inc. Common Stock
DSKE
$197K ﹤0.01%
+30,359
New +$220K
BELFB
1992
Bel Fuse Inc Class B
BELFB
$3.61B
$196K ﹤0.01%
+13,594
New +$224K
TLYS icon
1993
Tilly's
TLYS
$114M
$196K ﹤0.01%
12,286
-2,893
-19% -$39K
IACB.U
1994
DELISTED
ION Acquisition Corp 2 Ltd. Units, each consisting of one Class A ordinary share and one-eighth of o
IACB.U
$195K ﹤0.01%
19,300
-5,700
-23% -$57.8K
YARW
1995
Yarrow Bioscience
YARW
$105M
$194K ﹤0.01%
+61
New +$241K
ATRA icon
1996
Atara Biotherapeutics
ATRA
$98.8M
$193K ﹤0.01%
+498
New +$178K
HOOK
1997
DELISTED
HOOKIPA Pharma
HOOK
$193K ﹤0.01%
+2,109
New +$281K
TCPC icon
1998
BlackRock TCP Capital
TCPC
$351M
$193K ﹤0.01%
+13,992
New +$202K
TG icon
1999
Tredegar Corp
TG
$276M
$193K ﹤0.01%
+14,000
New +$211K
KOS icon
2000
Kosmos Energy
KOS
$1.63B
$192K ﹤0.01%
+55,370
New +$172K

Similar funds

Michael Gelband's Q2 2021 Portfolio in Review

As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.

  • Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
  • Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
  • Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
  • Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
  • Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
  • Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
  • Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.